George Golumbeski
Director · Acumen Pharmaceuticals, Inc.
Individual
- 2025
- Jun 5, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies George Golumbeski files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Arundathy N. Pandite - $409K in STTK purchases and sales in the last 12 months
- Clay B. Siegall - $250K in STTK purchases and sales in the last 12 months
- Abhinav A. Shukla - $183K in STTK purchases and sales in the last 12 months
- Derek M. Meisner - $105K in ABOS purchases and sales in the last 12 months
- Derrell Porter - $75K in ABOS purchases and sales in the last 12 months
- Daniel Joseph Oconnell - $22K in ABOS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is George Golumbeski?
George Golumbeski is a corporate insider, tracked as Director of Acumen Pharmaceuticals, Inc. (ABOS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did George Golumbeski last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 5 filings going back to 2025.
